Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.

Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdrawn the pending Biologics License Application (BLA ...

One thing we know about viruses is that they are bound to evolve and SARS-CoV-2, the virus that causes COVID-19, is no exception. Since the beginning of the pandemic, we have seen a number of its ...

The United States will limit Covid-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine ...